M&A - Fresenius Medical Care AG

Form Type: SCHEDULE 13D/A

Filing Date: 2025-03-06

Corporate Action: Acquisition

Type: Update

Accession Number: 000114036125007359

Filing Summary: Fresenius SE & Co. KGaA filed Amendment No. 10 to Schedule 13D reporting its acquisition of approximately 7.2% of shares of Fresenius Medical Care AG through private placements. On March 3, 2025, Fresenius KGaA entered into a Share Purchase Agreement and an Exchangeable Bond Subscription Agreement. The Share Purchase Agreement entails selling 10.6 million shares at EUR 44.50 per share, expected to close on March 6, 2025. The Exchangeable Bond Offering permits the sale of bonds worth up to EUR 600 million exchangeable into shares, closing on March 11, 2025. These transactions aim to optimize Fresenius KGaA's investment portfolio and enhance financial stability. Following these events, Fresenius KGaA will remain the largest shareholder with over 25% ownership of the company's shares. Fresenius KGaA intends to maintain its investment level while preserving strategic flexibility in a lock-up period of 180 days for share transactions post-closing.

Document Link: View Document